And still they are moving… Dynamic properties of caveolae  by Kurzchalia, Teymuras V. & Parton, Robert G.
FEBS Letters 389 (1996) 52-54 FEBS 17194 
Minireview 
And still they are moving... 
Dynamic properties of caveolae 
Teymuras V. Kurzchalia a,*, Robert G. Parton b 
aDepartment of Cell Biology, Max-Delbriick Centre for Molecular Medicine, Robert-R6ssle-Str. 10, 13 122 Berlin-Buch, Germany 
bCentre for Microscopy and Mieroanalysis, Department of Physiology and Pharmacology, University of Queensland, Brisbane, Qld. 4072, Australia 
Received 7 May 1996 
Abstract Caveolae are structures found on the surface of many 
mammalian cells. In the last few years the biogenesis and the 
function of these organelles have been intensively investigated but 
many challenging questions remain. One of these is whether 
caveolae are statically attached to the cytoplasmic surface of the 
plasma membrane or are moving to other intracellular orga- 
nelles. Also the cycling of the caveolar coat component, VIP21- 
caveolin, is a subject of intensive discussion. The solution to these 
problems could give an insight into the understanding of caveolar 
function. 
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1. Introduction 
While the function of many proteins is still unknown, there 
are very few cellular organelles today which have not been 
assigned a defined function. Caveolae belong to this group 
of organelles, although they were among the first cellular 
structures identified by electron microscopic studies [1,2]. As 
often happens, the lack of a clear-cut function led to the 
suggestion of many, sometimes mutually exclusive, possibili- 
ties. These include: an alternative ndocytic pathway [3-5]; 
transcytosis [6,7]; receptor-mediated uptake of small mole- 
cules (potocytosis; [8,9]); regulation of intracellular calcium 
concentration [10,11]; and signal transduction [12 14]. 
There are many interesting, still unsolved problems in the 
caveolar field. These include the biogenesis, the biochemical 
constitution and the function of this organelle, just to mention 
some of the major ones. However, the main issue of our 
minireview will be the dynamic properties of caveolae and 
their constituent VIP21-caveolin. 
2. Caveolae and VIP21-caveolin 
The original definition of caveolae was exclusively structur- 
al. The plasma membrane of many mammalian cells contains 
non-clathrin-coated membrane invaginations with diameter of 
40-60 nm (see for reviews [15,16]). The cytoplasmic surface of 
these structures i  covered by very characteristic multiple fila- 
ments [4,16-18], which are oriented in a parallel fashion or 
form spirals. The investigation of caveolae was significantly 
facilitated by the identification of VIP21-caveolin, a protein of 
21-22 kDa, which is so far the best biochemical or structural 
*Corresponding author. Fax: (49) (30) 9406 3592. 
0014-5793/96l$12.00 © 1996 Federation of European Biochemical Societies. 
P I IS0014-5793(96)00585-6  
marker for caveolae (for review see [19]). In their pioneering 
study Rothberg et al. have shown that antibodies against his 
protein decorate the caveolar coat filaments [18]. The surprise 
came when it became clear that in contrast o other vesicular 
coat constituents, VIP21-caveolin is an integral membrane 
protein [20]. The protein forms an unusual hairpin loop struc- 
ture in the membrane, with two cytoplasmically exposed re- 
gions flanking a very long hydrophobic segment [21-23]. In 
addition, the protein has two quite remarkable properties 
which are possibly connected to the structure of caveolae: it 
is insoluble in non-ionic detergents such as Triton X-100 or 
CHAPS [13,20] and it can associate with itself to form high 
molecular mass homo-oligomers in vivo as well as in vitro 
[23,24]. These oligomers could be structural elements of the 
caveolar coat. 
There is a link between caveolae (or VIP21-caveolin) and 
lipids. First, the addition of cholesterol-binding drugs like 
filipin or nystatin changes the morphology of caveolae, mak- 
ing them flat [18,25]. Second, caveolae are found in a Triton 
X-114-insoluble floating fraction (TIFF) [23], which is en- 
riched in glycosphingolipids a well as in cholesterol [26,27]. 
Moreover, as was recently shown, VIP21-caveolin itself could 
be a cholesterol-binding protein [28]. 
VIP21-caveolin appears to be a member of an emerging 
protein family. Recently two homologues of the protein 
have been identified [29-31], with one of these homologues 
being expressed exclusively in muscle [29,31]. In this review 
for the sake of simplicity, caveolin-1 will be used instead of 
VIP21-caveolin (see [41]). 
3. Static vs. mobile 
The discussion of whether caveolae are static invaginations 
on the cell surface or dynamic structures has a long history. In 
the beginning it was more or less accepted that they are pi- 
nocytic vesicles fixed in the process of budding from (or fusion 
with) the plasma membrane. In endothelial cells caveolae were 
ascribed the major role in the process of transcytosis (trans- 
endothelial transport) [6,32]. However, a number of investiga- 
tions in the mid-eighties questioned this assumption and an 
alternative view that caveolae are statically attached to the 
surface of endothelial cells was suggested (see for review 
[33]). Also the role of caveolae in the process of endocytosis 
remains unclarified. On the one hand studies on the interna- 
lization of cholera and tetanus toxins demonstrated the role of 
uncoated invaginations in this process [4,5] and these invagi- 
nations were subsequently shown to be identical to caveolae 
[34]. On the other hand van Deurs and colleagues categori- 
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cally argued against he involvement of caveolae in endocyto- 
sis [35]. 
Several recent papers shed new light on the dynamic prop- 
erties of caveolae. Recently two phenomena, dynamics of ca- 
veolae as an entity and the cycling of caveolin-1, were de- 
scribed. What are the new lines of evidence for these 
dynamic properties? 
4. What moves and how? 
One of the findings which gave hints of the dynamic proper- 
ties of caveolae was that treatment of cells with the phospha- 
tase inhibitor, okadaic acid, leads to a rapid decrease in the 
number of cell-surface attached caveolae [36]. This internali- 
zation process was blocked by cytochalasin D and by the 
kinase inhibitor staurosporine and apparently involved fusion 
of caveolae with endosomes. The effect of okadaic acid was 
most pronounced in hypertonic medium as groups of caveolae 
accumulated in the center of the cell close to the microtubule- 
organizing center. Interestingly, this process was reversible 
and dependent on an intact microtubule network. Presently, 
the molecular mechanisms of the internalization are not clear. 
However, one can speculate that the process is kinase depen- 
dent and is connected to the actin network. The main question 
remains whether the effect of this drug reveals a physiological 
process in which caveolae move between the surface and the 
center of the cell, for example in response to a plasma mem- 
brane stimulus. The fact that kinase inhibitors appeared to 
inhibit uptake via caveolae ven in the absence of okadaic 
acid [36] supports this idea. 
The above studies suggest a model for caveolae dynamics 
far removed from the potocytosis model proposed by Ander- 
son and co-workers [8]. In this model caveolae close transi- 
ently but do not move away from the plasma membrane. This 
process is also apparently regulated by phosphorylation as
protein kinase C activators inhibit the potocytosis cycle [37]. 
In this scheme caveolae do not interact with endosomes or 
other intracellular organelles. 
In such a model it might be predicted that caveolin-1, as an 
integral membrane protein which is apparently firmly em- 
bedded in the caveolar membrane, would not be transferred 
to other organelles. Interestingly, a third set of papers describe 
exactly such a phenomenon i which caveolin-1 cycles be- 
tween intracellular organelles and the plasma membrane. 
Smart and co-workers have investigated the influence of the 
membrane-impermeable enzyme cholesterol oxidase on the 
structure and the distribution of caveolae [38,39]. They ob- 
served that the oxidation of cholesterol led to a quantitative 
disappearance of caveolin-1 from the cell surface. Surpris- 
ingly, after the cholesterol oxidase treatment the number 
and the structure of caveolae, as revealed by electron micro- 
scopy, was unchanged. Therefore, the authors questioned 
whether caveolin-1 could per se be the main constituent of 
the caveolar coat. Even more surprising appeared to be the 
fate of caveolin-1 after the enzymatic treatment. The protein 
was first found in the rough ER and then migrated to the 
Golgi. At this stage caveolin-1 became detergent soluble, re- 
sistant o protease treatment and was localized in the lumen of 
these compartments. Removal of cholesterol oxidase led to 
the return of caveolin-1 to caveolae. It must be noted that 
this finding raises fundamental questions concerning much 
more than the cycling of caveolin-1. As mentioned earlier, 
the protein in the membrane is oriented towards the cyto- 
plasm and is part of a high molecular mass oligomer. The 
oxidation of cholesterol should lead to as yet undescribed 
post-translational rearrangements, even membrane-transloca- 
tion, of high molecular mass complexes. At first glance it is 
quite difficult to arrange these findings into the accepted para- 
digms of membrane translocation. Obviously, the verification 
and subsequent clarification of the molecular mechanisms of
this process are of tremendous importance. 
Further investigation of the caveolin-l-cycling phenomenon 
led to several new observations [40]. The authors argued that 
caveolin-1 must cycle constitutively between the plasma mem- 
brane and the Golgi apparatus. The cycling appears to be a 
complex process which includes microtubule-dependent as 
well as microtubule-independent steps. In particular, they 
showed that even in the absence of cholesterol oxidase, noca- 
dozole causes accumulation of the protein in the Golgi-ER 
intermediate compartment whereas the transport from Golgi 
to the plasma membrane is not affected by the drug. More- 
over, incubation of cells at 15°C led to accumulation of ca- 
veolin-1 in the intermediate compartment. One possible pro- 
viso to these studies is that it is not yet clear how general the 
phenomena described in these papers are. In contrast o the 
human fibroblast cell-line used by the authors, MDCK, HeLa 
and CHO cells appear not to show detectable r distribution of
caveolae upon cholesterol oxidase treatment or incubation at 
15°C (T.K., unpublished observations). Also the detergent- 
solubility or protease-resistance of caveolin-1 remain un- 
changed. All in all, much work is needed to clarify these 
complicated problems. 
5. Conclusions 
According to a growing body of experimental data, caveo- 
lae are not static invaginations on the plasma membrane. 
Undoubtedly they are capable of being internalized in a regu- 
lated manner under special conditions. However, it is still 
early to conclude that caveolae are permanently on the 
move and thus could be involved in a process imilar to en- 
docytosis. In our opinion the cycling of caveolin-1 also needs 
to be scrutinized using different cell types and different experi- 
mental conditions. In any case, this phenomenon, even if it is 
restricted to only a small number of cell-lines, deserves close 
attention, and dissection of the novel underlying principles. 
And still they move... 
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